FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395975005: Ergotamine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469915013 Ergotamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489605014 Ergotamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1883571000195114 ergotamina it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
809281000172115 ergotamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
402251000274116 Ergotamin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ergotamine (substance) Is a Ergot alkaloid false Inferred relationship Some
Ergotamine (substance) Is a alcaloïde peptidique false Inferred relationship Some
Ergotamine (substance) Is a agent pour le traitement de la migraine false Inferred relationship Some
Ergotamine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that is produced by a living organism and is toxic, noxious, or poisonous. true Inferred relationship Some
Ergotamine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha adrenergic receptor agonist (disposition) true Inferred relationship Some
Ergotamine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin receptor agonist true Inferred relationship Some
Ergotamine (substance) Is a Adrenergic receptor agonist false Inferred relationship Some
Ergotamine (substance) Is a Analgesic (substance) true Inferred relationship Some
Ergotamine (substance) Is a Substance with serotonin receptor agonist mechanism of action (substance) true Inferred relationship Some
Ergotamine (substance) Is a Alpha adrenergic receptor agonist false Inferred relationship Some
Ergotamine (substance) Is a Ergopeptide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Ergotamine measurement Component True Ergotamine (substance) Inferred relationship Some 1
Product containing ergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 1
Dihydroergotamine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Dihydroergotamine mesylate 4mg/1mL nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Dihydroergotamine mesylate 1mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Ergotamine tartrate (substance) Is a False Ergotamine (substance) Inferred relationship Some
Product containing dihydroergotamine mesylate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Ergotamine withdrawal Causative agent (attribute) False Ergotamine (substance) Inferred relationship Some 1
Product containing dihydroergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Product containing dihydroergotamine mesylate in oral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Oxytocin and ergometrine adverse reaction Causative agent (attribute) False Ergotamine (substance) Inferred relationship Some 2
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Dihydroergotamine mesilate 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Dihydroergotamine (substance) Is a False Ergotamine (substance) Inferred relationship Some
Product containing caffeine and ergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 2
Ergotamine + caffeine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Ergotamine tartrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Ergotamine (substance) Inferred relationship Some
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some
Product containing ergotamine in sublingual dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine (substance) Inferred relationship Some 1
Product containing caffeine and ergotamine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 2
Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 3
Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 3
Caffeine- and ergotamine-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 2
Ergotamine-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 1
Product containing only belladonna alkaloid and ergotamine and phenobarbital (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 3
Product containing only caffeine and ergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 2
Ergotamine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 1
Caffeine and ergotamine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 2
Product containing only caffeine and ergotamine in rectal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 2
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 3
Ergotamine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ergotamine (substance) Inferred relationship Some 1
Ergotamine dependence (disorder) Causative agent (attribute) True Ergotamine (substance) Inferred relationship Some 1
Medication overuse headache caused by ergotamine (finding) Causative agent (attribute) True Ergotamine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start